Janus Henderson Investors US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Janus Henderson Investors US’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$65.2M	Buy	4,409,717 +717,643	+19%	+$11.6M	0.05%	376
2016 Q4	$59.7M	Sell	3,692,074 -123,739	-3%	-$2.24M	0.05%	403
2016 Q3	$69.2M	Sell	3,815,813 -225,931	-6%	-$4.41M	0.06%	365
2016 Q2	$66.6M	Sell	4,041,744 -378,266	-9%	-$6.12M	0.06%	371
2016 Q1	$73.2M	Buy	4,420,010 +1,246,752	+39%	+$21.8M	0.06%	346
2015 Q4	$68.8M	Buy	3,173,258 +350,092	+12%	+$6.81M	0.06%	347
2015 Q3	$56M	Buy	2,823,166 +1,929,471	+216%	+$61M	0.05%	385
2015 Q2	$31M	Buy	+893,695	New	+$27.3M	0.03%	525

Other funds holding HZNP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Janus Henderson Investors US's HZNP Position: Q1 2017 in Review

Janus Henderson Investors US increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 19% in Q1 2017, buying an estimated $11.6M and bringing the position to 4,409,717 shares worth $65.2M. The position accounts for 0.05% of the portfolio, ranked #376.

Janus Henderson Investors US first reported a position in HZNP in Q2 2015 and has held it in 8 quarters since. The position peaked at $73.2M in Q1 2016. 210 funds tracked by Wall St. Rank hold HZNP as of Q1 2017.

Janus Henderson Investors US held 4,409,717 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $65.2M as of Q1 2017.
Janus Henderson Investors US bought 717,643 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2017, an estimated $11.6M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.05% of Janus Henderson Investors US's portfolio in Q1 2017, its #376 holding.
Janus Henderson Investors US first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and has held it in 8 quarters since.
Janus Henderson Investors US's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $73.2M in Q1 2016.
210 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.